SEC Form D · filed March 21, 2024
Calidi Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Boris Minev · San Diego, CAExecAndrew Jackson · San Diego, CAExecJames A. Schoeneck · San Diego, CADirectorScott R. Leftwich · San Diego, CADirectorAlan R. Stewart · San Diego, CADirectorAllan Camaisa · San Diego, CAExec · DirectorWendy Pizarro · San Diego, CAExecDavid A. Lapre · San Diego, CADirectorGeorge R. Ng · San Diego, CADirectorTony W. Goodman · Glen Allen, VADirectorDavid A. Lapre · San Diego, CADirectorCary J. Claiborne · Glen Allen, VAExecDonald H. Kagin · Tiburon, CAExecJames W. Newman, Jr · Glen Allen, VADirectorVinay J. Shah · Glen Allen, VAExec · DirectorAndrew Jackson · San Diego, CAExecAlan R. Stewart · San Diego, CADirectorJames K. Anderson · Glen Allen, VADirectorErica H. Radcliffe · Houston, TXExec · DirectorJohn A. Hill · Stamford, CTDirectorEdward T. Bialas · Stamford, CTExecNeil A. Wizel · Stamford, CTExecAlex T. Krueger · Stamford, CTDirectorGary D. Reaves, Ii · Stamford, CTDirectorJohn W. Thiel · New York, NYDirectorRichard Skeet · London, United KingdomDirectorYechuan Zhang · London, United KingdomExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗